Safety and Efficacy of Radiopharmaceuticals 1987

  • Knud Kristensen
  • Elisabeth Nørbygaard

Part of the Developments in Nuclear Medicine book series (DNUM, volume 14)

Table of contents

  1. Front Matter
    Pages I-XIV
  2. Safety and Efficacy of Radiopharmaceuticals with Emphasis on Biological Products

    1. Front Matter
      Pages 1-1
    2. Knud Kristensen, Elisabeth Nørbygaard
      Pages 3-4
    3. J. C. Saccavini, J. F. Chatal, M. Kremer
      Pages 5-19
    4. K. H. Bremer, A. Schwarz
      Pages 43-50
    5. S. J. Mather
      Pages 51-66
    6. Erling Sundrehagen
      Pages 67-76
    7. O. Svendsen, H. B. Christensen, P. Juul, J. Rygaard
      Pages 105-114
    8. Harriet Dige-Petersen
      Pages 207-216
  3. Radiopharmacy/Radiation Hygiene

    1. Front Matter
      Pages 223-223
    2. Knud Kristensen, Elisabeth Nørbygaard
      Pages 225-225
    3. Klaus Ennow
      Pages 249-259
    4. Asker Aarkrog
      Pages 261-268
  4. Legal Aspects of the Introduction of New Radiopharmaceuticals

    1. Front Matter
      Pages 269-269
    2. Knud Kristensen, Elisabeth Nørbygaard
      Pages 271-271
    3. Harriet Dige-Petersen, Per Juul
      Pages 279-287
  5. Selected Aspects of Good Radiopharmacy Practice

    1. Front Matter
      Pages 315-315
    2. Knud Kristensen, Elisabeth Nørbygaard
      Pages 317-317
    3. E. Bachmann
      Pages 339-344
    4. C. B. Sampson
      Pages 345-362
  6. Back Matter
    Pages 369-371

About this book


Safety and Efficacy of Radiopharmaceuticals was established as a very important and comprehensive subject at the First Europe­ an Symposium on Radiopharmacy and Radiopharmaceuticals in Denmark in 1983. The interest in this subject has grown considerably since then due to the growing interest among national authorities to deal with radiopharmaceuticals. The introduction in recent years of nuclear medicine techniques based on radioactive labelled cells and on monoclonal antibodies has stressed the importance of a well functioning approval system for the clinical trial and use of new radiopharmaceuticals. The process of transferring the experience from the non radioactive drug field into the area of radiopharmaceuticals is still ongoing. International organisations such as the World Health Organisa­ tion is also including this into their quality assurance programme from both the radiopharmaceutical and the radiation hygiene point of view. In order to give an up-to date survey of these areas, experts were invited to prepare review papers under the following headings: Safety and Efficacy of Radiophar­ maceuticals with Emphasis on Biological Products, Radiophar­ macy/Radiation Hygiene, Legal Aspects of the Introduction of New Radiopharmaceuticals and some selected aspects of Good Radiopharmacy Practice.


development diagnosis drugs pharmaceutical radiation tumor

Editors and affiliations

  • Knud Kristensen
    • 1
  • Elisabeth Nørbygaard
    • 1
  1. 1.The Isothope PharmacyThe National Board of HealthCopenhagenDenmark

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media B.V. 1987
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-94-010-8016-3
  • Online ISBN 978-94-009-3375-0
  • Buy this book on publisher's site